P32 Sodium Phosphate (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the P32 Sodium Phosphate drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: P32 Sodium Phosphate
SUBSTANCE NAME: PHOSPHORUS P-32
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTERSTITIAL; INTRA-ARTICULAR; INTRAPERITONEAL; INTRAPLEURAL
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-06-19
END MARKETING DATE: 0000-00-00


P32 Sodium Phosphate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionP32 Sodium Phosphate from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mCi/mL)
START MARKETING DATE: 2012-06-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-127_5ed86373-1e27-42fc-a3b3-b198944f0dff
PRODUCT NDC: 51808-127
APPLICATION NUMBER:

Other PHOSPHORUS P-32 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationP32 Sodium Phosphate